QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sagar, S. M. Articles by Martin, J. B. Search for Related Content PubMed PubMed Citation Articles by Sagar, S. M. Articles by Martin, J. B.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 2, 225-231, Copyright © 1982 by Society for Neuroscience

ARTICLE

Depletion of somatostatin-like immunoreactivity in the rat central nervous system by cysteamine

SM Sagar, D Landry, WJ Millard, TM Badger, MA Arnold and JB Martin

Selective neurotoxins have been of value in providing a means for specifically interfering with the actions of endogenous neurotransmitter candidates. Others have shown cysteamine (CSH) to deplete the gastrointestinal tract and hypothalamus of rats of immunoreactive somatostatin, suggesting a toxic action of that compound directed against somatostatin-containing cells. The present study further defines the actions of cysteamine on somatostatin in the central nervous system. (CNS). Cysteamine hydrochloride administered subcutaneously results in a depletion of somatostatin-like immunoreactivity (SLI) in the retina, brain, and cervical spinal cord of rats. The effect is demonstrable at doses of 30 mg/kg of body weight and above, occurs within 2 to 4 hr of a single injection of the drug, and is largely reversible within 1 week. The mean depletion of SLI observed within the CNS varies from 38% in cerebral cortex to 65% in cervical spinal cord 24 hr following administration of CSH, 300 mg/kg of body weight, s.c. By gel permeation chromatography, all molecular weight forms of SLI are affected, with the largest reductions in those forms that co-chromatograph with synthetic somatostatin-14 and somatostatin-28. These results indicate that CSH has a generalized, rapid, and largely reversible effect in depleting SLI from the rat CNS.

This article has been cited by other articles:

				C. Kluge, C. Stoppel, C. Szinyei, O. Stork, and H.-C. Pape Role of the somatostatin system in contextual fear memory and hippocampal synaptic plasticity Learn. Mem., April 3, 2008; 15(4): 252 - 260. [Abstract] [Full Text] [PDF]

				N. Iijima, Y. Matsumoto, T. Yano, M. Tanaka, T. Yamamoto, K. Kakihara, Y. Kataoka, Y. Tamada, H. Matsumoto, N. Suzuki, et al. A Novel Function of Prolactin-Releasing Peptide in the Control of Growth Hormone via Secretion of Somatostatin from the Hypothalamus Endocrinology, July 1, 2001; 142(7): 3239 - 3243. [Abstract] [Full Text] [PDF]

				N. Matsuoka and T. G. Aigner FK960 [N-(4-Acetyl-1-piperazinyl)-p-fluorobenzamide Monohydrate], a Novel Potential Antidementia Drug, Improves Visual Recognition Memory in Rhesus Monkeys: Comparison with Physostigmine J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1201 - 1209. [Abstract] [Full Text]

				W. Millard, S. Sagar, D. Landis, and J. Martin Cysteamine: a potent and specific depletor of pituitary prolactin Science, July 30, 1982; 217(4558): 452 - 454. [Abstract] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help